{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/07/30/3336054/0/en/Newly-FDA-Approved-REVTORPYK-gedatolisib-Included-in-the-National-Comprehensive-Cancer-Network-NCCN-Clinical-Practice-Guidelines-for-HR-HER2-Locally-Advanced-or-Metastatic-Breast-C.html", "message": "News view counter 858073 successfully enlarged"}